EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer



A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer



Cancer Research 56(21): 4862-4864



We examined the relationship of a common polymorphism (667C fwdarw T) of the methylenetetrahydrofolate reductase (MTHFR) gene with the risk of colorectal cancer in a case-control study conducted in the Health Professionals Follow-up Study. MTHFR genotypes were ascertained from blood samples among 144 men previously diagnosed with colorectal cancer and 627 controls. The adjusted odds ratio (OR) for the MTHFR variant homozygous (val/val) genotype was 0.57 (95% confidence interval (CT), 0.30-1.06). High dietary intake of methionine (OR, 0.27; 95% CT, 0.061.20) and low consumption of alcohol (OR, 0.11; 95% CT, 0.01-0.85) were associated with reduced incidence of colorectal cancer. Alcohol intake was a stronger risk factor among men with the val/val genotype (P, trend = 0.01), and consumption of rive or more alcoholic drinks per week abolished the reduced risk of colorectal cancer among val/val individuals (P, interaction = 0.02). The inverse association of methionine with colorectal cancer risk was slightly stronger among individuals with the MTHFR val/val genotype. These data suggest that dietary methyl supply is particularly critical among MTHFR val/val individuals. When dietary methyl supply is high, MTHFR val/val individuals may be at reduced risk of colorectal cancer probably because higher levels of 5,10-methylenetetrahydrofolate may prevent imbalances of nucleotide pools during DNA synthesis. In contrast, when 5-methyltetrahydrofolate is depleted by alcohol consumption, val/val individuals may be less able to compensate, leading to potentially oncogenic alterations in DNA methylation.

(PDF 0-2 workdays service: $29.90)

Accession: 002738475

Download citation: RISBibTeXText

PMID: 8895734



Related references

Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Research 57(6): 1098-1102, 1997

Risk of colorectal cancer associated with the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the Kashmiri population. Genetics and Molecular Research 10(2): 1200-1210, 2011

Methylenetetrahydrofolate reductase C677T gene polymorphism and colorectal cancer risk: A case-control study. Oncology Letters 4(2): 365-369, 2012

The interactive effect of methyl-group diet and polymorphism of methylenetetrahydrofolate reductase on the risk of colorectal cancer. Mutation Research 622(1-2): 14-18, 2007

Risk of colorectal cancer associated with the C677T polymorphism in 5,10-methylenetetrahydrofolate reductase in Portuguese patients depends on the intake of methyl-donor nutrients. American Journal of Clinical Nutrition 88(5): 1413-1418, 2008

Methylenetetrahydrofolate reductase polymorphism and risk of colorectal adenomas. Cancer Letters 151(2): 181-186, 2000

A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal adenoma. Proceedings of the American Association for Cancer Research Annual Meeting 38(0): 213, 1997

The methylenetetrahydrofolate reductase 677CfwdarwT polymorphism and distal colorectal adenoma risk. Cancer Epidemiology Biomarkers & Prevention 9(7): 657-663, July, 2000

The methylenetetrahydrofolate reductase 677C-->T polymorphism and distal colorectal adenoma risk. Cancer Epidemiology, Biomarkers & Prevention 9(7): 657-663, 2000

Colorectal cancer and polymorphism of methylenetetrahydrofolate reductase C677T in Morocco. Journal africain du cancer / African Journal of Cancer 4(4): 238-244, 2012

Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer. Cell Biochemistry and Function 25(4): 419-422, 2006

Methylenetetrahydrofolate reductase polymorphism in colorectal cancer Lack of association with K-ras mutation. Proceedings of the American Association for Cancer Research Annual Meeting 39: 628, March, 1998

Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer in a Korean population. Bmc Cancer 10(): 236-236, 2010

Breast cancer risk and methylenetetrahydrofolate reductase polymorphism. Breast Cancer Research and Treatment 77(3): 217-223, 2003

The 677C > T mutation in 5,10-methylenetetrahydrofolate reductase and colorectal cancer risk. Genetic Testing 3(2): 233-236, 1999